Long-term effects of proglumide on resection of cardiac adenocarcinoma

Table 1 Clinicopathologic characteristics of the patients.

	Proglumide treated group	Control group	χ2	P
n	153	148
Sex (M/F)	115/38	122/26	2.374	0.123
Age (mean)	59.6	57.5	1.463	0.226
Location
Cardiac	71	72	0.152	0.697
Cardiac & lower	82	76
esophagus
Tumor size
<3 cm	17	11	1.321	0.517
3-5 cm	27	25
>5 cm	109	112
Margin cancer
Not stated	132	132	0.917	0.632
Upper margin (+)	15	10
Lower margin (+)	6	6
Property of resection
Radical (grade A+B)	102	91	0.877	0.349
Palliative (grade C)	51	57
Differentiation
High and moderate	93	84	0.774	0.856
Poor	38	40
Undifferentiated	6	5
Mucinous	16	19
adenocarcinoma
Depth of invasion
Muscular layer	35	36	2.342	0.310
Tunica serosa	98	84
Infiltration	20	28
Lymph node metastasis
(-)	61	62	0.127	0.721
(+)	92	86
Stage
I	19	11	3.120	0.374
II	43	52
III	82	77
IV	9	8